These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 18311777)
21. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential. Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272 [TBL] [Abstract][Full Text] [Related]
22. The clinical significance of serrated polyps. Huang CS; Farraye FA; Yang S; O'Brien MJ Am J Gastroenterol; 2011 Feb; 106(2):229-40; quiz 241. PubMed ID: 21045813 [TBL] [Abstract][Full Text] [Related]
23. Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer. Kohonen-Corish MR; Sigglekow ND; Susanto J; Chapuis PH; Bokey EL; Dent OF; Chan C; Lin BP; Seng TJ; Laird PW; Young J; Leggett BA; Jass JR; Sutherland RL Oncogene; 2007 Jun; 26(30):4435-41. PubMed ID: 17260021 [TBL] [Abstract][Full Text] [Related]
24. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter. Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773 [TBL] [Abstract][Full Text] [Related]
25. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Grieu F; Watanabe G; Iacopetta B Br J Cancer; 2006 Feb; 94(4):593-8. PubMed ID: 16421593 [TBL] [Abstract][Full Text] [Related]
26. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Oh K; Redston M; Odze RD Hum Pathol; 2005 Jan; 36(1):101-11. PubMed ID: 15712188 [TBL] [Abstract][Full Text] [Related]
27. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088 [TBL] [Abstract][Full Text] [Related]
28. APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer. Iacopetta B; Grieu F; Li W; Ruszkiewicz A; Caruso M; Moore J; Watanabe G; Kawakami K Int J Cancer; 2006 Nov; 119(10):2272-8. PubMed ID: 16981189 [TBL] [Abstract][Full Text] [Related]
29. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Suzuki H; Igarashi S; Nojima M; Maruyama R; Yamamoto E; Kai M; Akashi H; Watanabe Y; Yamamoto H; Sasaki Y; Itoh F; Imai K; Sugai T; Shen L; Issa JP; Shinomura Y; Tokino T; Toyota M Carcinogenesis; 2010 Mar; 31(3):342-9. PubMed ID: 19638426 [TBL] [Abstract][Full Text] [Related]
31. Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression. Ibrahim AE; Arends MJ; Silva AL; Wyllie AH; Greger L; Ito Y; Vowler SL; Huang TH; Tavaré S; Murrell A; Brenton JD Gut; 2011 Apr; 60(4):499-508. PubMed ID: 21068132 [TBL] [Abstract][Full Text] [Related]
32. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis. Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156 [TBL] [Abstract][Full Text] [Related]
33. Unmasking early colorectal cancer clues: in silico and in vitro investigation of downregulated IGF2, SOCS1, MLH1, and CACNA1G in SSA polyps. Mirbahari SN; Fatemi N; Savabkar S; Chaleshi V; Zali N; Taleghani MY; Mirzaei E; Rejali L; Moghadam PK; Mojarad EN Mol Biol Rep; 2024 Jun; 51(1):764. PubMed ID: 38874740 [TBL] [Abstract][Full Text] [Related]
34. Role of the BRAF mutations in the microsatellite instability genetic pathway in sporadic colorectal cancer. Maestro ML; Vidaurreta M; Sanz-Casla MT; Rafael S; Veganzones S; Martínez A; Aguilera C; Herranz MD; Cerdán J; Arroyo M Ann Surg Oncol; 2007 Mar; 14(3):1229-36. PubMed ID: 17195912 [TBL] [Abstract][Full Text] [Related]
35. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118 [TBL] [Abstract][Full Text] [Related]
36. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Srivastava A; Redston M; Farraye FA; Yantiss RK; Odze RD Am J Surg Pathol; 2008 Feb; 32(2):296-303. PubMed ID: 18223333 [TBL] [Abstract][Full Text] [Related]
37. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942 [TBL] [Abstract][Full Text] [Related]
38. Origin of colorectal cancers in hyperplastic polyps and serrated adenomas: another truism bites the dust. Hamilton SR J Natl Cancer Inst; 2001 Sep; 93(17):1282-3. PubMed ID: 11535695 [No Abstract] [Full Text] [Related]
39. Highly methylated genes in colorectal neoplasia: implications for screening. Zou H; Harrington JJ; Shire AM; Rego RL; Wang L; Campbell ME; Oberg AL; Ahlquist DA Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2686-96. PubMed ID: 18086775 [TBL] [Abstract][Full Text] [Related]
40. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Deng G; Chen A; Hong J; Chae HS; Kim YS Cancer Res; 1999 May; 59(9):2029-33. PubMed ID: 10232580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]